Using topiramate in patients with epilepsy: practical aspects (Q77100624)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706736%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

review article

1 reference

title

Using topiramate in patients with epilepsy: practical aspects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706736%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

J W Sander

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706736%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706736%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

2 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706736%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706736%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706736%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

S16-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706736%20AND%20SRC:MED&resulttype=core&format=json

Drug interaction profile of topiramate

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034867

7 January 2021

Safety of topiramate: adverse events and relationships to dosing

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034867

7 January 2021

Preliminary open-label experience with topiramate in primary generalized seizures

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034867

7 January 2021

Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034867

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034867

7 January 2021

Difficulties in extrapolating from clinical trial data to clinical practice: The case of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034867

7 January 2021

The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goal

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034867

7 January 2021

Topiramate: a new antiepileptic drug for refractory epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034867

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100034867

7 January 2021

10.1017/S0317167100034867

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706736%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9706736%20AND%20SRC:MED&resulttype=core&format=json